Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms?
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Medical Association
2017
|
| _version_ | 1826292773556322304 |
|---|---|
| author | Taylor, J Irani, S |
| author_facet | Taylor, J Irani, S |
| author_sort | Taylor, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T03:19:52Z |
| format | Journal article |
| id | oxford-uuid:b70ef669-a242-4d69-8da6-13cc4794c372 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:19:52Z |
| publishDate | 2017 |
| publisher | American Medical Association |
| record_format | dspace |
| spelling | oxford-uuid:b70ef669-a242-4d69-8da6-13cc4794c3722022-03-27T04:45:41ZBortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms?Journal articlehttp://purl.org/coar/resource_type/c_545buuid:b70ef669-a242-4d69-8da6-13cc4794c372EnglishSymplectic Elements at OxfordAmerican Medical Association2017Taylor, JIrani, S |
| spellingShingle | Taylor, J Irani, S Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title | Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title_full | Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title_fullStr | Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title_full_unstemmed | Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title_short | Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms? |
| title_sort | bortezomib for neuromyelitis optica spectrum disorder a new therapeutic option for the more severe forms |
| work_keys_str_mv | AT taylorj bortezomibforneuromyelitisopticaspectrumdisorderanewtherapeuticoptionforthemoresevereforms AT iranis bortezomibforneuromyelitisopticaspectrumdisorderanewtherapeuticoptionforthemoresevereforms |